To access this element change to forms mode OFF
Grant Award View - GA201503
Risk and resilience in Alzheimer's pathogenesis, cognitive decline and...
GA ID:
GA201503
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,306,096.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Risk and resilience in Alzheimer's pathogenesis, cognitive decline and clinical disease progression
Purpose:
Alzheimer’s disease is the most common form of dementia, and the number of people living with it will triple by 2050. There is currently no cure for Alzheimer’s disease, and the only means of slow the growing epidemic is to delay onset. My research program aims to identify risk and resilience factors of Alzheimer’s disease. This will uncover novel disease-modifying strategies, improve clinical trial design, and develop algorithms that will predict individuals’ rate of disease progression.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009550
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA